Ability of Four Toothpastes to Remove Plaque

Inclusion Criteria

• Demonstrates understanding of the study and willingness to participate as evidenced by voluntary written informed consent and has received a signed and dated copy of the informed consent form.
• Aged at least 18 years
• Understands and is willing, able and likely to comply with all study procedures and restrictions
• Good general health with (in the opinion of the Investigator) no clinically significant and relevant abnormalities of medical history or dental history.
• Good dental health based on medical history and oral soft tissue examination at screening
• At least 20 gradable, natural, uncrowned teeth with both facial and lingual scoreable surfaces (gradable teeth are those where restorative materials cover less than 25% of the tooth surface graded)
• Plaque Score: Mean Turesky plaque score of ≥ 2.00 at treatment visit 1 pre-brushing plaque assessment

Exclusion Criteria

• Women who are known to be pregnant or who are intending to become pregnant over the duration of the study
• Women who are breast-feeding
• Antibiotic treatment within 14 days prior to Treatment Visit 1 or throughout the study
• Any other treatment that would interfere with the study results/conduct, at the discretion of the examiner or investigator
• Diabetes mellitus type I or II
• Any disease systemic or localized, dental or non dental, which could put the participant's health at risk or interfere with the study results/conduct, at the discretion of the examiner or investigator
• High levels of extrinsic stain or calculus deposits which might interfere with plaque assessments
• Dental condition/ disease requiring immediate treatment
• Pre-existing sensitivity to oral care products
• Severe gingivitis
• Periodontitis with pocket depth > 5mm affecting more than two teeth
• Moderate or severe recession
• Presence of orthodontic bands or appliances, extensive crowns, partial dentures, or fixed retainers on the maxillary or mandibular teeth
• Obvious active carious lesions needing immediate care
• Intra-oral decorative tattoos, or tongue and or lip piercing
• Oral lesions/manifestations that would impact on the outcome of the study
• Presence of oral or peri-oral ulceration including herpetic lesions at the time of screening or at baseline
• Known or suspected intolerance or hypersensitivity to the studymaterials (or closely related compounds) or any of their stated ingredients
• Participation in another clinical study or receipt of an investigational drug within 30 days of the screening visit
• Previous participation in this study
• Recent history (within the last year) of alcohol or other substance abuse
• Current use of Listerine or any antimicrobial mouth rinse containing Chlorhexidine or Cetrylpyridinium Chloride (CPC)
• Participant unwilling to abstain from using chewing tobacco (with or without tobacco)
• Participant unwilling to abstain from smoking on the morning prior to treatment visits
• An employee of the sponsor or the study site or members of their immediate family